YG
Gloor, Yvonne Sylvia
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Evaluation of important human CYP450 isoforms and P-glycoprotein phenotype changes and genotype in type 2 diabetic patients, before and after intensifying treatment regimen using Geneva cocktail | Basic & clinical pharmacology & toxicology |  | 2023 | 92 | 0 | ||
| Impact of obesity and bariatric surgery on metabolic enzymes and p-glycoprotein activity using the Geneva cocktail approach | Journal of personalized medicine |  | 2023 | 82 | 18 | ||
| Uncovering a Genetic Polymorphism Located in Huntingtin Associated Protein 1 in Modulation of Central Pain Sensitization Signaling Pathways | Frontiers in neuroscience | | 2022 | 379 | 64 | ||
| Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting | Journal of personalized medicine | | 2022 | 199 | 179 | ||
| Genetic Susceptibility Toward Nausea and Vomiting in Surgical Patients | Frontiers in genetics | | 2022 | 213 | 116 | ||
| Liquid Biopsy for Patient Characterization in Cardiovascular Disease: Verification against Markers of Cytochrome P450 and P-Glycoprotein Activities | Clinical pharmacology & therapeutics | | 2022 | 157 | 307 | ||
| Impact of SARS-CoV-2 Infection (COVID-19) on Cytochromes P450 Activity Assessed by the Geneva Cocktail | Clinical pharmacology and therapeutics | | 2021 | 184 | 105 | ||
| Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity | British journal of pharmacology | | 2021 | 294 | 120 | ||
| Reviewing Data Integrated for PBPK Model Development to Predict Metabolic Drug-Drug Interactions: Shifting Perspectives and Emerging Trends | Frontiers in pharmacology | | 2021 | 158 | 162 | ||
| Impact of acute inflammation on cytochromes P450 activity assessed by the Geneva Cocktail | Clinical Pharmacology and Therapeutics | | 2020 | 300 | 405 | ||
| Cytochrome P450 1A2 activity and incidence of thyroid disease and cancer after chronic or acute exposure to dioxins | Basic & Clinical Pharmacology & Toxicology | | 2019 | 435 | 4 | ||
| Early biomarker discovery of paracetamol-induced hepato-toxicity after therapeutic doses: experimental tool implementation | | 2017 | 88 | 1 |
